Parkman Healthcare Partners as of Sept. 30, 2020
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 84 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Therapeutics Pub L SHS | 4.9 | $18M | 237k | 77.68 | |
| Danaher Corporation (DHR) | 3.7 | $14M | 65k | 215.33 | |
| Neurocrine Biosciences (NBIX) | 3.4 | $13M | 133k | 96.16 | |
| Natera (NTRA) | 3.4 | $13M | 175k | 72.24 | |
| Dex (DXCM) | 3.2 | $12M | 30k | 412.22 | |
| Humana (HUM) | 2.9 | $11M | 27k | 413.90 | |
| Merck & Co (MRK) | 2.8 | $10M | 126k | 82.95 | |
| Edwards Lifesciences (EW) | 2.6 | $9.8M | 123k | 79.82 | |
| Turning Point Therapeutics I | 2.6 | $9.6M | 110k | 87.36 | |
| Charles River Laboratories (CRL) | 2.4 | $9.1M | 40k | 226.45 | |
| Axonics Modulation Technolog (AXNX) | 2.4 | $9.0M | 177k | 51.04 | |
| Vericel (VCEL) | 2.2 | $8.3M | 450k | 18.53 | |
| Iqvia Holdings (IQV) | 2.2 | $8.3M | 53k | 157.63 | |
| Masimo Corporation (MASI) | 2.2 | $8.3M | 35k | 236.06 | |
| Silk Road Medical Inc Common (SILK) | 2.1 | $8.1M | 120k | 67.21 | |
| Catalent (CTLT) | 2.0 | $7.7M | 90k | 85.66 | |
| Insulet Corporation (PODD) | 2.0 | $7.7M | 33k | 236.59 | |
| Immunic (IMUX) | 2.0 | $7.4M | 400k | 18.57 | |
| GenMark Diagnostics | 1.8 | $6.8M | 480k | 14.20 | |
| Abbvie (ABBV) | 1.7 | $6.6M | 75k | 87.59 | |
| UnitedHealth (UNH) | 1.7 | $6.5M | 21k | 311.75 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.6 | $6.1M | 23k | 272.12 | |
| Dicerna Pharmaceuticals | 1.6 | $5.9M | 326k | 17.99 | |
| Itamar Med Sponsored Ads | 1.5 | $5.7M | 281k | 20.43 | |
| Alexion Pharmaceuticals | 1.5 | $5.7M | 50k | 114.44 | |
| Acceleron Pharma | 1.5 | $5.6M | 50k | 112.52 | |
| Kodiak Sciences (KOD) | 1.5 | $5.5M | 93k | 59.21 | |
| Trillium Therapeutics Com New | 1.4 | $5.3M | 375k | 14.21 | |
| Nuance Communications | 1.4 | $5.3M | 160k | 33.19 | |
| Immunovant (IMVT) | 1.4 | $5.3M | 150k | 35.19 | |
| Seaspine Holdings | 1.4 | $5.3M | 369k | 14.30 | |
| Xenon Pharmaceuticals (XENE) | 1.4 | $5.1M | 465k | 11.07 | |
| Icad Com New (ICAD) | 1.4 | $5.1M | 582k | 8.81 | |
| Gw Pharmaceuticals Ads | 1.3 | $4.9M | 50k | 97.36 | |
| Aclaris Therapeutics (ACRS) | 1.3 | $4.7M | 1.8M | 2.57 | |
| Repro-Med Systems (KRMD) | 1.2 | $4.6M | 631k | 7.22 | |
| Alnylam Pharmaceuticals (ALNY) | 1.2 | $4.5M | 31k | 145.61 | |
| Smiledirectclub Cl A Com (SDCCQ) | 1.1 | $4.2M | 360k | 11.68 | |
| Arcus Biosciences Incorporated (RCUS) | 1.1 | $4.0M | 235k | 17.14 | |
| Zymeworks | 1.0 | $4.0M | 85k | 46.58 | |
| Peregrine Pharmaceuticals (CDMO) | 1.0 | $3.7M | 484k | 7.62 | |
| Kadmon Hldgs | 0.9 | $3.4M | 875k | 3.92 | |
| Alphatec Hldgs Com New (ATEC) | 0.8 | $3.0M | 452k | 6.64 | |
| InfuSystem Holdings (INFU) | 0.8 | $3.0M | 233k | 12.82 | |
| IDEXX Laboratories (IDXX) | 0.8 | $2.9M | 7.5k | 393.07 | |
| Molecular Templates | 0.8 | $2.9M | 268k | 10.92 | |
| Bridgebio Pharma (BBIO) | 0.7 | $2.8M | 75k | 37.53 | |
| 89bio (ETNB) | 0.7 | $2.8M | 110k | 25.66 | |
| BioCryst Pharmaceuticals (BCRX) | 0.7 | $2.8M | 801k | 3.44 | |
| Mersana Therapeutics (MRSN) | 0.7 | $2.6M | 140k | 18.62 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.7 | $2.6M | 60k | 43.07 | |
| Axsome Therapeutics (AXSM) | 0.7 | $2.5M | 35k | 71.24 | |
| Schrodinger (SDGR) | 0.6 | $2.4M | 50k | 47.52 | |
| Kala Pharmaceuticals | 0.6 | $2.3M | 310k | 7.50 | |
| Stereotaxis Com New (STXS) | 0.6 | $2.3M | 644k | 3.58 | |
| Madrigal Pharmaceuticals (MDGL) | 0.6 | $2.2M | 18k | 118.72 | |
| Sutro Biopharma (STRO) | 0.6 | $2.1M | 210k | 10.05 | |
| Avrobio Ord (AVRO) | 0.6 | $2.1M | 161k | 13.02 | |
| Eidos Therapeutics | 0.5 | $2.1M | 41k | 50.52 | |
| Aurinia Pharmaceuticals (AUPH) | 0.5 | $1.9M | 130k | 14.73 | |
| Novavax Com New (NVAX) | 0.5 | $1.9M | 18k | 108.34 | |
| Nephros (NEPH) | 0.5 | $1.7M | 241k | 7.23 | |
| Meiragtx Holdings (MGTX) | 0.5 | $1.7M | 131k | 13.24 | |
| Misonix | 0.4 | $1.6M | 136k | 11.73 | |
| Castle Biosciences (CSTL) | 0.4 | $1.5M | 30k | 51.46 | |
| Axogen (AXGN) | 0.4 | $1.5M | 125k | 11.63 | |
| Surface Oncology | 0.4 | $1.4M | 200k | 6.90 | |
| Inovalon Hldgs Com Cl A | 0.4 | $1.3M | 50k | 26.46 | |
| Profound Med Corp Com New (PROF) | 0.3 | $1.2M | 70k | 17.64 | |
| Quidel Corporation | 0.3 | $1.1M | 5.0k | 219.36 | |
| Rapt Therapeutics (RAPT) | 0.3 | $966k | 30k | 32.19 | |
| Catabasis Pharmaceuticals In Com New | 0.2 | $901k | 146k | 6.19 | |
| Catalyst Biosciences Com New | 0.2 | $896k | 209k | 4.30 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.2 | $864k | 200k | 4.32 | |
| Mannkind Corp Com New (MNKD) | 0.2 | $660k | 351k | 1.88 | |
| Forte Biosciences (FBRX) | 0.2 | $606k | 13k | 48.48 | |
| Edap Tms S A Sponsored Adr (EDAP) | 0.2 | $575k | 125k | 4.60 | |
| Goodrx Hldgs Com Cl A (GDRX) | 0.1 | $556k | 10k | 55.60 | |
| Amarin Corp Spons Adr New (AMRN) | 0.1 | $489k | 116k | 4.21 | |
| Atreca Cl A Com (BCEL) | 0.1 | $489k | 35k | 13.97 | |
| Aprea Therapeutics | 0.1 | $482k | 20k | 24.05 | |
| Aerpio Pharmaceuticals | 0.1 | $450k | 300k | 1.50 | |
| Syndax Pharmaceuticals (SNDX) | 0.1 | $443k | 30k | 14.76 | |
| Outset Med (OM) | 0.1 | $350k | 7.0k | 50.00 |
